Invited Speakers
-
Keynote
Saralyn Mark
Saralyn Mark, MD, an endocrinologist, geriatrician and women's health specialist is the founder, president and CEO of SolaMed Solutions, LLC, a boutique consulting firm. In this capacity, she has served as a medical and scientific policy advisor providing scientific and strategic direction for organizations and agencies including the White House Office of Science and Technology Policy, the Bill and Melinda Gates Foundation Strategic Investment Fund, academia, industry, and non-governmental and professional society organizations. She is also the founder and president of iGIANT®, the only nonprofit in the world accelerating the translation of research into gender/sex-specific design elements across all sectors.
Dr. Mark was the first Senior Medical Advisor to the Office on Women's Health within the Department of Health and Human Services for 11 years and to the National Aeronautics and Space Administration (NASA) for 18 years and served on the NASA Steering Committee on Precision Innovation for Space Exploration. As Senior Medical Advisor, Dr. Mark was responsible for the development and analysis of initiatives and programs on emerging technologies, public health preparedness, physician workforce issues, sex and gender-based medicine and women's health on Earth and in space.
As a pioneer in women's health, she designed the first women's health fellowship in the United States, helped create the National Centers of Leadership in Academic Medicine, the National Centers of Excellence in Women's Health in academic and community health centers across the country and landmark educational campaigns on critical health issues.
Dr. Mark is a Diplomate of the National Board of Medical Examiners and had been the civilian representative to the Surgeon General Physician Advisory Committee. She has chaired or served on over 60 national and international editorial and advisory boards, commissions and task forces including the President's Interagency Council on Women, the National Institutes of Health Federal Work Group on Bone Diseases, the NASA Medical Policy Board, NCQA HEDIS Measurement Advisory Panel, the United Nations (UN) Global Commission on Women's Health, the UN Council on Gender Health, APCO Worldwide International and Healthcare Advisory Councils, the Society for Women's Health Research Board, and the Dean’s Scientific Advisory Board for George Mason University. She is the lead/spokesperson on COVID-19 for the American Medical Women’s Association (AMWA) and the XPrize Health and Pandemic Alliance Brain Trust.
Dr. Mark is an Associate Professor adjunct at the Yale University School of Medicine in the Departments of Medicine, and Obstetrics and Gynecology as well as at the Georgetown University School of Medicine. Dr. Mark is also an Affiliate Professor and Distinguished Senior Fellow in the School of Public Policy at George Mason University and a visiting Senior Lecturer at Kings College - London. She is an alumna of the New York University School of Medicine and Barnard College of Columbia University and completed her residency, fellowships and first academic appointment at the University of California at San Francisco School of Medicine (UCSF). In 2014, she was awarded an honorary Doctor of Laws degree from Wayne State University School of Medicine following her commencement address.
Dr. Mark has published and delivered over 700 lectures in the United States and abroad. Dr. Mark was invited by the White House to testify about her work on precision innovation for the National Space Council which is led by the Vice President. She is the author of Stellar Medicine: A Journey Through the Universe of Women's Health (Brick Tower Press). She has made over 600 television, radio, on-line and print appearances including CNN, NBC, ABC, Fox, Forbes, Business Insider and The Washington Post. Dr. Mark has received many accolades and awards from the federal government and prominent medical organizations such as the Secretary of Health Award for Distinguished Public Service, the Assistant Secretary of Health Award for Outstanding Team Performance and the Gynecologic Cancer Foundation's Public Service Award. She is the recipient of the AMWA Lila A. Wallis Award for Lifetime Achievement in Women's Health and the NYU School of Medicine Alumni Leadership Award. Dr. Mark continues to foster the development of innovative programs, policies and products that affect the lives of people around the world.Read more
Saralyn Mark
Saralyn Mark, MD, an endocrinologist, geriatrician and women's health specialist is the founder, president and CEO of SolaMed Solutions, LLC, a boutique consulting firm. In this capacity, she has served as a medical and scientific policy advisor providing scientific and strategic direction for organizations and agencies including the White House Office of Science and Technology Policy, the Bill and Melinda Gates Foundation Strategic Investment Fund, academia, industry, and non-governmental and professional society organizations. She is also the founder and president of iGIANT®, the only nonprofit in the world accelerating the translation of research into gender/sex-specific design elements across all sectors.
Dr. Mark was the first Senior Medical Advisor to the Office on Women's Health within the Department of Health and Human Services for 11 years and to the National Aeronautics and Space Administration (NASA) for 18 years and served on the NASA Steering Committee on Precision Innovation for Space Exploration. As Senior Medical Advisor, Dr. Mark was responsible for the development and analysis of initiatives and programs on emerging technologies, public health preparedness, physician workforce issues, sex and gender-based medicine and women's health on Earth and in space.
As a pioneer in women's health, she designed the first women's health fellowship in the United States, helped create the National Centers of Leadership in Academic Medicine, the National Centers of Excellence in Women's Health in academic and community health centers across the country and landmark educational campaigns on critical health issues.
Dr. Mark is a Diplomate of the National Board of Medical Examiners and had been the civilian representative to the Surgeon General Physician Advisory Committee. She has chaired or served on over 60 national and international editorial and advisory boards, commissions and task forces including the President's Interagency Council on Women, the National Institutes of Health Federal Work Group on Bone Diseases, the NASA Medical Policy Board, NCQA HEDIS Measurement Advisory Panel, the United Nations (UN) Global Commission on Women's Health, the UN Council on Gender Health, APCO Worldwide International and Healthcare Advisory Councils, the Society for Women's Health Research Board, and the Dean’s Scientific Advisory Board for George Mason University. She is the lead/spokesperson on COVID-19 for the American Medical Women’s Association (AMWA) and the XPrize Health and Pandemic Alliance Brain Trust.
Dr. Mark is an Associate Professor adjunct at the Yale University School of Medicine in the Departments of Medicine, and Obstetrics and Gynecology as well as at the Georgetown University School of Medicine. Dr. Mark is also an Affiliate Professor and Distinguished Senior Fellow in the School of Public Policy at George Mason University and a visiting Senior Lecturer at Kings College - London. She is an alumna of the New York University School of Medicine and Barnard College of Columbia University and completed her residency, fellowships and first academic appointment at the University of California at San Francisco School of Medicine (UCSF). In 2014, she was awarded an honorary Doctor of Laws degree from Wayne State University School of Medicine following her commencement address.
Dr. Mark has published and delivered over 700 lectures in the United States and abroad. Dr. Mark was invited by the White House to testify about her work on precision innovation for the National Space Council which is led by the Vice President. She is the author of Stellar Medicine: A Journey Through the Universe of Women's Health (Brick Tower Press). She has made over 600 television, radio, on-line and print appearances including CNN, NBC, ABC, Fox, Forbes, Business Insider and The Washington Post. Dr. Mark has received many accolades and awards from the federal government and prominent medical organizations such as the Secretary of Health Award for Distinguished Public Service, the Assistant Secretary of Health Award for Outstanding Team Performance and the Gynecologic Cancer Foundation's Public Service Award. She is the recipient of the AMWA Lila A. Wallis Award for Lifetime Achievement in Women's Health and the NYU School of Medicine Alumni Leadership Award. Dr. Mark continues to foster the development of innovative programs, policies and products that affect the lives of people around the world. -
Keynote
Sir Michael G. Marmot
Professor, University College London
Sir Michael Marmot has been Professor of Epidemiology at University College London since 1985. He is the author of The Health Gap: the challenge of an unequal world (Bloomsbury: 2015), and Status Syndrome: how your place on the social gradient directly affects your health (Bloomsbury: 2004). Professor Marmot is the Advisor to the WHO Director-General, on social determinants of health, in the new WHO Division of Healthier Populations; Distinguished Visiting Professor at Chinese University of Hong Kong (2019-), and co-Director of the of the CUHK Institute of Health Equity. He is the recipient of the WHO Global Hero Award; the Harvard Lown Professorship (2014-2017); the Prince Mahidol Award for Public Health (2015), and 19 honorary doctorates. Marmot has led research groups on health inequalities for nearly 50 years. He chaired the Commission on Equity and Health Inequalities in the Americas, set up in 2015 by the World Health Organization’s Pan-American Health Organization (PAHO/ WHO) and chaired the Commission on Social Determinants of Health (CSDH), which was set up by the World Health Organization in 2005, and produced the report entitled: ‘Closing the Gap in a Generation’ in August 2008. At the request of the British Government, he conducted the Strategic Review of Health Inequalities in England post 2010, which published its report 'Fair Society, Healthy Lives' in February 2010. This was followed by the European Review of Social Determinants of Health and the Health Divide, for WHO EURO in 2014; Health Equity in England: Marmot Review 10 Years On, in 2020; Build Back Fairer: the COVID-19 Marmot Review in 2021; and the Report of the Commission on Social Determinants of Health in the Eastern Mediterranean Region, for WHO EMRO, also in 2021.
Professor Marmot also chaired the Expert Panel for the WCRF/AICR 2007 Second Expert Report on Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective; the Breast Screening Review for the NHS National Cancer Action Team, and was a member of The Lancet-University of Oslo Commission on Global Governance for Health. Early in his career, he set up and led a number of longitudinal cohort studies on the social gradient in health in the UCL Department of Epidemiology & Public Health (where he was head of department for 25 years): the Whitehall II Studies of British Civil Servants, investigating explanations for the striking inverse social gradient in morbidity and mortality; the English Longitudinal Study of Ageing (ELSA), and several international research efforts on the social determinants of health. He served as President of the British Medical Association (BMA) in 2010-2011, and as President of the World Medical Association in 2015. He is President of the British Lung Foundation. He is an Honorary Fellow of the American College of Epidemiology; a Fellow of the Academy of Medical Sciences; an Honorary Fellow of the British Academy, and an Honorary Fellow of the Faculty of Public Health of the Royal College of Physicians. He was a member of the Royal Commission on Environmental Pollution for six years and in 2000 he was knighted by Her Majesty The Queen, for services to epidemiology and the understanding of health inequalities. Professor Marmot is a Member of the National Academy of Medicine.
http://www.instituteofhealthequity.org/
See: https://iris.ucl.ac.uk/iris/browse/profile?upi=MGMAR64Read more
Sir Michael G. Marmot
Professor, University College London
Sir Michael Marmot has been Professor of Epidemiology at University College London since 1985. He is the author of The Health Gap: the challenge of an unequal world (Bloomsbury: 2015), and Status Syndrome: how your place on the social gradient directly affects your health (Bloomsbury: 2004). Professor Marmot is the Advisor to the WHO Director-General, on social determinants of health, in the new WHO Division of Healthier Populations; Distinguished Visiting Professor at Chinese University of Hong Kong (2019-), and co-Director of the of the CUHK Institute of Health Equity. He is the recipient of the WHO Global Hero Award; the Harvard Lown Professorship (2014-2017); the Prince Mahidol Award for Public Health (2015), and 19 honorary doctorates. Marmot has led research groups on health inequalities for nearly 50 years. He chaired the Commission on Equity and Health Inequalities in the Americas, set up in 2015 by the World Health Organization’s Pan-American Health Organization (PAHO/ WHO) and chaired the Commission on Social Determinants of Health (CSDH), which was set up by the World Health Organization in 2005, and produced the report entitled: ‘Closing the Gap in a Generation’ in August 2008. At the request of the British Government, he conducted the Strategic Review of Health Inequalities in England post 2010, which published its report 'Fair Society, Healthy Lives' in February 2010. This was followed by the European Review of Social Determinants of Health and the Health Divide, for WHO EURO in 2014; Health Equity in England: Marmot Review 10 Years On, in 2020; Build Back Fairer: the COVID-19 Marmot Review in 2021; and the Report of the Commission on Social Determinants of Health in the Eastern Mediterranean Region, for WHO EMRO, also in 2021.
Professor Marmot also chaired the Expert Panel for the WCRF/AICR 2007 Second Expert Report on Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective; the Breast Screening Review for the NHS National Cancer Action Team, and was a member of The Lancet-University of Oslo Commission on Global Governance for Health. Early in his career, he set up and led a number of longitudinal cohort studies on the social gradient in health in the UCL Department of Epidemiology & Public Health (where he was head of department for 25 years): the Whitehall II Studies of British Civil Servants, investigating explanations for the striking inverse social gradient in morbidity and mortality; the English Longitudinal Study of Ageing (ELSA), and several international research efforts on the social determinants of health. He served as President of the British Medical Association (BMA) in 2010-2011, and as President of the World Medical Association in 2015. He is President of the British Lung Foundation. He is an Honorary Fellow of the American College of Epidemiology; a Fellow of the Academy of Medical Sciences; an Honorary Fellow of the British Academy, and an Honorary Fellow of the Faculty of Public Health of the Royal College of Physicians. He was a member of the Royal Commission on Environmental Pollution for six years and in 2000 he was knighted by Her Majesty The Queen, for services to epidemiology and the understanding of health inequalities. Professor Marmot is a Member of the National Academy of Medicine.
http://www.instituteofhealthequity.org/
See: https://iris.ucl.ac.uk/iris/browse/profile?upi=MGMAR64 -
Keynote
Mei-Hua Wang
Minister of Ministry of Economic Affairs, R.O.C (Taiwan)
Minister Wang has spent all her career in the Ministry of Economic Affairs (MOEA) for almost forty years. She is the third female Minister in MOEA’s history.
MOEA is the Ministry responsible for policies relating to industrial and commercial development, international trade, foreign investment, energy and other economic issues.
Before serving as the Vice Minister and the Deputy Minister of MOEA, she was a renowned IP expert with 20 years’ experience of working at the Intellectual Property Office.
She successfully builds trust with the industries because of her personality with communication and coordination skills, and practical experience in trade negotiation.
Minister Wang took office in 2020 and focus on energy transition, industrial upgrading, investment promotion, and economic integration.Read more
Mei-Hua Wang
Minister of Ministry of Economic Affairs, R.O.C (Taiwan)
Minister Wang has spent all her career in the Ministry of Economic Affairs (MOEA) for almost forty years. She is the third female Minister in MOEA’s history.
MOEA is the Ministry responsible for policies relating to industrial and commercial development, international trade, foreign investment, energy and other economic issues.
Before serving as the Vice Minister and the Deputy Minister of MOEA, she was a renowned IP expert with 20 years’ experience of working at the Intellectual Property Office.
She successfully builds trust with the industries because of her personality with communication and coordination skills, and practical experience in trade negotiation.
Minister Wang took office in 2020 and focus on energy transition, industrial upgrading, investment promotion, and economic integration. -
Plenary Speakers
Chen, Chien-Jen
Prof. Chen, Chien-Jen received his Sc.D. in epidemiology and human genetics from the Johns Hopkins University (1983). He then worked as an associate professor (1983-1986) and professor (1986-2006) of National Taiwan University. He was jointly appointed as a research fellow of Academia Sinica (1986-2005). He was appointed as the director of Graduate Institute of Public Health (1993-1994), founding director of Graduate Institute of Epidemiology (1994-1997), and dean of College of Public Health in National Taiwan University (1999-2002). He became a distinguished research fellow of Genomics Research Center of Academia Sinica (2006-2015), and was appointed as a vice president of the academy (2011-2015). He was appointed as the Minister of Department of Health (2003-2005) and Minister of National Science Council (2006-2008). He was elected as the 14th Vice President of the Republic of China (Taiwan). He is now an academician and distinguished research fellow of Genomics Research Center, Academia Sinica.
Prof. Chen has dedicated himself to molecular and genomic epidemiological research on chronic arsenic poisoning and virus-induced cancers over 40 years. His discoveries of multiple health hazards of arsenic in drinking water has led to the global awareness and mitigation of the largest environmental calamity, and his research on end-stage liver disease risk prediction of chronic hepatitis B has pioneered the viral load paradigm in its clinical management. He has published over 760 scientific articles and over 75 books/chapters, which have been cited for over 106,000 times with an H-index of 150 (Google Scholar).
Prof. Chen was elected as an academician of Academia Sinica (1998), a member of World Academy of Sciences (2005), an honorary member of Mongolian Academy of Sciences (2007), a Foreign Associate (international member) of US National Academy of Sciences (2017), and an academician of Pontifical Academy of Sciences (2021).
He has received many awards and honors including the Presidential Science Prize (2005) and the Order of Dr. Sun Yat-sen with Grand Cordon (2020) in Taiwan, the Cutter Lectureship on Preventive Medicine of Harvard University (2008) and the Knowledge for the World Award of Johns Hopkins University (2012) in the USA, the Officier of the Ordre des Palmes Académiques (2009) in France, the Knight of the Equestrian Order of the Holy Sepulchre (2010) and the Pontifical Equestrian Order of St. Gregory the Great (2013) in Vatican. He received honorary doctoral degrees from China Medical University (2014), National Sun Yet-Sen University (2020), and Kaohsiung Medical University (2020) in Taiwan.Read more
Chen, Chien-Jen
Prof. Chen, Chien-Jen received his Sc.D. in epidemiology and human genetics from the Johns Hopkins University (1983). He then worked as an associate professor (1983-1986) and professor (1986-2006) of National Taiwan University. He was jointly appointed as a research fellow of Academia Sinica (1986-2005). He was appointed as the director of Graduate Institute of Public Health (1993-1994), founding director of Graduate Institute of Epidemiology (1994-1997), and dean of College of Public Health in National Taiwan University (1999-2002). He became a distinguished research fellow of Genomics Research Center of Academia Sinica (2006-2015), and was appointed as a vice president of the academy (2011-2015). He was appointed as the Minister of Department of Health (2003-2005) and Minister of National Science Council (2006-2008). He was elected as the 14th Vice President of the Republic of China (Taiwan). He is now an academician and distinguished research fellow of Genomics Research Center, Academia Sinica.
Prof. Chen has dedicated himself to molecular and genomic epidemiological research on chronic arsenic poisoning and virus-induced cancers over 40 years. His discoveries of multiple health hazards of arsenic in drinking water has led to the global awareness and mitigation of the largest environmental calamity, and his research on end-stage liver disease risk prediction of chronic hepatitis B has pioneered the viral load paradigm in its clinical management. He has published over 760 scientific articles and over 75 books/chapters, which have been cited for over 106,000 times with an H-index of 150 (Google Scholar).
Prof. Chen was elected as an academician of Academia Sinica (1998), a member of World Academy of Sciences (2005), an honorary member of Mongolian Academy of Sciences (2007), a Foreign Associate (international member) of US National Academy of Sciences (2017), and an academician of Pontifical Academy of Sciences (2021).
He has received many awards and honors including the Presidential Science Prize (2005) and the Order of Dr. Sun Yat-sen with Grand Cordon (2020) in Taiwan, the Cutter Lectureship on Preventive Medicine of Harvard University (2008) and the Knowledge for the World Award of Johns Hopkins University (2012) in the USA, the Officier of the Ordre des Palmes Académiques (2009) in France, the Knight of the Equestrian Order of the Holy Sepulchre (2010) and the Pontifical Equestrian Order of St. Gregory the Great (2013) in Vatican. He received honorary doctoral degrees from China Medical University (2014), National Sun Yet-Sen University (2020), and Kaohsiung Medical University (2020) in Taiwan. -
Plenary Speakers
Chang-Chuan Chan
Chan is a Distinguished Professor at the Institute of Environmental and Occupational Health Sciences, College of Public Health (CPH), National Taiwan University (NTU). He was the 9th Dean of CPH, and Director of the Global Health Center and Population Health Research Center at NTU. He is a member of the APRU Global Health Program Advisory Group, head of Taiwan delegations for M8 Alliance, and Chair of International Advisory Board for the Reform for Resilience Commission Asia-Pacific Hub. Chan was also councilor of the ISEE (2015-2017), councilor of the ISES (2008-2011), Chair of the ISEE - Asia and Western Pacific Chapter (2016-2020), and Chair of Taiwan Society for Risk Analysis (2008-2015).
Chan received his ScD and MSc from Harvard T.H. Chan School of Public Health, and BSc in Public Health from NTU. He has been a leading researcher in air pollution for more than twenty years, with over 200 SCI publications.Read more
Chang-Chuan Chan
Chan is a Distinguished Professor at the Institute of Environmental and Occupational Health Sciences, College of Public Health (CPH), National Taiwan University (NTU). He was the 9th Dean of CPH, and Director of the Global Health Center and Population Health Research Center at NTU. He is a member of the APRU Global Health Program Advisory Group, head of Taiwan delegations for M8 Alliance, and Chair of International Advisory Board for the Reform for Resilience Commission Asia-Pacific Hub. Chan was also councilor of the ISEE (2015-2017), councilor of the ISES (2008-2011), Chair of the ISEE - Asia and Western Pacific Chapter (2016-2020), and Chair of Taiwan Society for Risk Analysis (2008-2015).
Chan received his ScD and MSc from Harvard T.H. Chan School of Public Health, and BSc in Public Health from NTU. He has been a leading researcher in air pollution for more than twenty years, with over 200 SCI publications. -
Plenary Speakers
Dale Fisher
Professor Dale Fisher is an Australian infectious diseases physician who first moved to the National University Hospital, Singapore in March 2003 during the SARS outbreak. He has had many leadership roles in international outbreak missions. In Singapore he is the Group chief of Medicine at National University Health Systems and leads many efforts for the Ministry of Health including chairing the National Infection Prevention and Control Committee. He is chair of the steering committee of WHO’s Global Outbreak Alert & Response Network. Additionally, he has supported many WHO guideline efforts and was one of 12 international technical experts who visited China in February 2020 to investigate the COVID-19 outbreak. He has authored over 200 peer-reviewed publications and given over 130 invited and plenary presentations at international conferences. He was recently presented Singapore’s National Outstanding Clinician Award, 2021.
Read more
Dale Fisher
Professor Dale Fisher is an Australian infectious diseases physician who first moved to the National University Hospital, Singapore in March 2003 during the SARS outbreak. He has had many leadership roles in international outbreak missions. In Singapore he is the Group chief of Medicine at National University Health Systems and leads many efforts for the Ministry of Health including chairing the National Infection Prevention and Control Committee. He is chair of the steering committee of WHO’s Global Outbreak Alert & Response Network. Additionally, he has supported many WHO guideline efforts and was one of 12 international technical experts who visited China in February 2020 to investigate the COVID-19 outbreak. He has authored over 200 peer-reviewed publications and given over 130 invited and plenary presentations at international conferences. He was recently presented Singapore’s National Outstanding Clinician Award, 2021.
-
Plenary Speakers
Silvia Sara Canetto
Silvia Sara Canetto, Ph.D., is Professor of Psychology at Colorado State University, USA. She has graduate degrees from the University of Padova, Italy; the Hebrew University of Jerusalem, Israel, and Northwestern University, Chicago, USA. Her scholarship focuses on women and men in science and engineering; on women’s human rights; and on scripts of gender and suicidal behaviors. Prof. Canetto has been honored with several prestigious awards, including the Heritage Award of the Society for the Psychology of Women, American Psychological Association; and the Denmark-Gunvald Award of the International Council of Psychologists. Prof. Canetto is “Fellow” of the American Psychological Association; the Society for the Psychology of Women, the Society for the Psychological Study of Men and Masculinities; the Association for Psychological Science; and the Gerontological Society of America.
Read more
Silvia Sara Canetto
Silvia Sara Canetto, Ph.D., is Professor of Psychology at Colorado State University, USA. She has graduate degrees from the University of Padova, Italy; the Hebrew University of Jerusalem, Israel, and Northwestern University, Chicago, USA. Her scholarship focuses on women and men in science and engineering; on women’s human rights; and on scripts of gender and suicidal behaviors. Prof. Canetto has been honored with several prestigious awards, including the Heritage Award of the Society for the Psychology of Women, American Psychological Association; and the Denmark-Gunvald Award of the International Council of Psychologists. Prof. Canetto is “Fellow” of the American Psychological Association; the Society for the Psychology of Women, the Society for the Psychological Study of Men and Masculinities; the Association for Psychological Science; and the Gerontological Society of America.
-
Plenary Speakers
Alice Yu
Dr. Alice Yu is an Academician, a Distinguished Professor & Co-Director of the Institute of Stem Cell & Cancer Translational Research in Chang Gung Memorial Hospital at Linko, Taiwan, and a Professor Emeritus at the University of California in San Diego (UCSD). Formerly, she was the Chief of Pediatric Hematology/Oncology at UCSD, and the distinguished research fellow and deputy director of the Genomics Research Center of Academia Sinica in Taiwan.
Dr. Yu received her MD at the National Taiwan University, and a PhD in microbiology/ immunology at University of Chicago. As a pioneer in cancer immunotherapy, Dr. Yu has taken an anti-GD2 monoclonal antibody (Dinutuximab) from IND application through phase III clinical trial, culminating in its FDA approval for the treatment of high-risk neuroblastoma in 2015. This marks the first immunotherapeutic agent worldwide to target a non-protein molecule, thereby widening the net of potential pharmaceutical targets. Her group has also uncovered the roles of the most prevalent cancer associated glycan, Globo H, as an immune checkpoint molecule and an angiogenic factor, providing rationales for the ongoing development of Globo H-targeted immunotherapeutics. Her group is investigating the use of NKT-stimulatory glycolipids as anti-cancer therapeutics and vaccine adjuvants. In addition, Dr. John Yu and her group have developed strategies to target cancer stem cells by identifying a novel protein, TMCC3, as a marker for cancer stem cells, and developing antibody drug conjugate for cancer therapy. They also identified peptides that bind to GRP78 on the surface of cancer stem cells, but not normal cells and developed novel cancer therapeutics using the optimized cancer targeting peptides as “guided missiles” for a broad spectrum of cancer types and preferentially targeting “cancer stem cell”, for which they received the 16th National Innovation Award.
Dr. Yu has received many other awards including 2020 ASCO Pediatric Oncology Award, Academic Award from the Ministry of Education, Wang Min-Ning Memorial Award for Outstanding Contribution to the Development Medical Science and Technology, and “Key to Life” Award from the Leukemia & Lymphoma Society, USA, Excellence in Technology Transfer Award 2016 from Federal Laboratory Consortium, USA.Read more
Alice Yu
Dr. Alice Yu is an Academician, a Distinguished Professor & Co-Director of the Institute of Stem Cell & Cancer Translational Research in Chang Gung Memorial Hospital at Linko, Taiwan, and a Professor Emeritus at the University of California in San Diego (UCSD). Formerly, she was the Chief of Pediatric Hematology/Oncology at UCSD, and the distinguished research fellow and deputy director of the Genomics Research Center of Academia Sinica in Taiwan.
Dr. Yu received her MD at the National Taiwan University, and a PhD in microbiology/ immunology at University of Chicago. As a pioneer in cancer immunotherapy, Dr. Yu has taken an anti-GD2 monoclonal antibody (Dinutuximab) from IND application through phase III clinical trial, culminating in its FDA approval for the treatment of high-risk neuroblastoma in 2015. This marks the first immunotherapeutic agent worldwide to target a non-protein molecule, thereby widening the net of potential pharmaceutical targets. Her group has also uncovered the roles of the most prevalent cancer associated glycan, Globo H, as an immune checkpoint molecule and an angiogenic factor, providing rationales for the ongoing development of Globo H-targeted immunotherapeutics. Her group is investigating the use of NKT-stimulatory glycolipids as anti-cancer therapeutics and vaccine adjuvants. In addition, Dr. John Yu and her group have developed strategies to target cancer stem cells by identifying a novel protein, TMCC3, as a marker for cancer stem cells, and developing antibody drug conjugate for cancer therapy. They also identified peptides that bind to GRP78 on the surface of cancer stem cells, but not normal cells and developed novel cancer therapeutics using the optimized cancer targeting peptides as “guided missiles” for a broad spectrum of cancer types and preferentially targeting “cancer stem cell”, for which they received the 16th National Innovation Award.
Dr. Yu has received many other awards including 2020 ASCO Pediatric Oncology Award, Academic Award from the Ministry of Education, Wang Min-Ning Memorial Award for Outstanding Contribution to the Development Medical Science and Technology, and “Key to Life” Award from the Leukemia & Lymphoma Society, USA, Excellence in Technology Transfer Award 2016 from Federal Laboratory Consortium, USA. -
Symposium
Dabota Yvonne Buowari
Dr Dabota Yvonne Buowari, MD,
Dabota Yvonne Buowari is a Nigerian doctor working at the Department of Accident and emergency at the University of Port Harcourt Teaching Hospital, Port Harcourt. Nigeria
She is the Vice-Chair of the MWIA Work-Life Balance Special Interest Group, 2019-2022
Co-Researcher in the MWIA survey on sexual harassment at the workplace
Her activities at her state branch of the Medical Women’s Association of Nigeria (MWAN) include secretary of the continuous medical education and violence against women and girls committee.
She is the Co-Chair of the Research Statistics Committee of the Nigeria Association of Resident Doctors, 2021
During the MWIA Near East and Africa Regional Conference in 2021, she organised a symposium on violence against doctors with a focus on women doctors. She spoke on workplace violence in healthcare. She is a member of several research groups. She has contributed recipes to several cookbooks. Some of her poems on COVID-19 have been published in the JDN Newsletter.
She has contributed recipes published in the American Medical Women’s Association Diversity and Inclusion Section Commemorative Cultural Cookbook, MWIA centennial recipe book, Medical Women's Association of Nigeria newsletters and the Premier African Lifestyle Medicine magazine.
Dabota is a lover of arts, this made her join the American Medical Women’s Association (AMWA) dance, theatre and medicine taskforce. She has authored some books about her home town and an article published in Festivals and Tours Africa magazine titled 'The Cloth Known as George Wrapper' a cloth cherished in southern Nigeria.
Awards
• Third place, Lifebox poetry contest
• Third place, Nigerian Medical Association 2017/2018 essay contest
• Certificate of excellence, Nigerian Association of Resident Doctors, 2020
• Researcher of the Year, Society of Lifestyle Medicine of Nigeria, January 6, 2021
• First prize, poster presentation, MWIA Central Asia Regional Conference, 2021
• Best free paper presentation, MWIA Western Pacific Regional Conference, 2021
• Best poster presentation at the MWIA Western Pacific Regional Conference, 2021
• 2021 Academy for Women in Academic Emergency Medicine/Global Emergency Medicine Academy Global Experienced Emergency Medicine Travel Award
Dabota is also an author, historian and poet.Read more
Dabota Yvonne Buowari
Dr Dabota Yvonne Buowari, MD,
Dabota Yvonne Buowari is a Nigerian doctor working at the Department of Accident and emergency at the University of Port Harcourt Teaching Hospital, Port Harcourt. Nigeria
She is the Vice-Chair of the MWIA Work-Life Balance Special Interest Group, 2019-2022
Co-Researcher in the MWIA survey on sexual harassment at the workplace
Her activities at her state branch of the Medical Women’s Association of Nigeria (MWAN) include secretary of the continuous medical education and violence against women and girls committee.
She is the Co-Chair of the Research Statistics Committee of the Nigeria Association of Resident Doctors, 2021
During the MWIA Near East and Africa Regional Conference in 2021, she organised a symposium on violence against doctors with a focus on women doctors. She spoke on workplace violence in healthcare. She is a member of several research groups. She has contributed recipes to several cookbooks. Some of her poems on COVID-19 have been published in the JDN Newsletter.
She has contributed recipes published in the American Medical Women’s Association Diversity and Inclusion Section Commemorative Cultural Cookbook, MWIA centennial recipe book, Medical Women's Association of Nigeria newsletters and the Premier African Lifestyle Medicine magazine.
Dabota is a lover of arts, this made her join the American Medical Women’s Association (AMWA) dance, theatre and medicine taskforce. She has authored some books about her home town and an article published in Festivals and Tours Africa magazine titled 'The Cloth Known as George Wrapper' a cloth cherished in southern Nigeria.
Awards
• Third place, Lifebox poetry contest
• Third place, Nigerian Medical Association 2017/2018 essay contest
• Certificate of excellence, Nigerian Association of Resident Doctors, 2020
• Researcher of the Year, Society of Lifestyle Medicine of Nigeria, January 6, 2021
• First prize, poster presentation, MWIA Central Asia Regional Conference, 2021
• Best free paper presentation, MWIA Western Pacific Regional Conference, 2021
• Best poster presentation at the MWIA Western Pacific Regional Conference, 2021
• 2021 Academy for Women in Academic Emergency Medicine/Global Emergency Medicine Academy Global Experienced Emergency Medicine Travel Award
Dabota is also an author, historian and poet. -
Plenary Speakers
Heidi Stensmyren
Dr Heidi Stensmyren is President of the World Medical Association (WMA). She previously
served as Chair of the WMA Medical Ethics Committee 2017-2019 and has actively participated in
several WMA working groups, including on WMA Governance, the Declaration of Geneva and the
International Code of Medical Ethics.
Dr. Stensmyren is an anesthesia and intensive care specialist. 2014-2020 she was President
of the Swedish Medical Association (SMA) as well as Chair of the SMA Negotiation Committee
and Chair of The Swedish Medical Journal. She has also chaired the Swedish Council for Organ
and Tissue Donation and Transplantation at the National Board of Health and Welfare. She has
been an expert in two recent Swedish national enquiries regarding organ and tissue donation and
transplantation. Dr. Stensmyren has been a committee member of the Swedish government's Life
Science Advisory Board and board member of Research Sweden. She has also served as board
member of the Swedish Agency for Health Technology Assessment and Assessment of Social
Services.
Dr Stensmyren is currently Managing Director at the Women's Health and Allied Health
Professionals Department, Karolinska University Hospital in Stockholm, Sweden.Read more
Heidi Stensmyren
Dr Heidi Stensmyren is President of the World Medical Association (WMA). She previously
served as Chair of the WMA Medical Ethics Committee 2017-2019 and has actively participated in
several WMA working groups, including on WMA Governance, the Declaration of Geneva and the
International Code of Medical Ethics.
Dr. Stensmyren is an anesthesia and intensive care specialist. 2014-2020 she was President
of the Swedish Medical Association (SMA) as well as Chair of the SMA Negotiation Committee
and Chair of The Swedish Medical Journal. She has also chaired the Swedish Council for Organ
and Tissue Donation and Transplantation at the National Board of Health and Welfare. She has
been an expert in two recent Swedish national enquiries regarding organ and tissue donation and
transplantation. Dr. Stensmyren has been a committee member of the Swedish government's Life
Science Advisory Board and board member of Research Sweden. She has also served as board
member of the Swedish Agency for Health Technology Assessment and Assessment of Social
Services.
Dr Stensmyren is currently Managing Director at the Women's Health and Allied Health
Professionals Department, Karolinska University Hospital in Stockholm, Sweden.